Omega-3, Metabolic Syndrome, and Schizophrenia: A review | ||
Journal of Patient Safety & Quality Improvement | ||
مقاله 7، دوره 5، شماره 1، فروردین 2017، صفحه 502-504 اصل مقاله (446 K) | ||
نوع مقاله: Review Article | ||
شناسه دیجیتال (DOI): 10.22038/psj.2017.8163 | ||
نویسندگان | ||
Seyedeh Narjes Roudbaraki* 1؛ Fatemeh Behdani1؛ Paria Hebrani1؛ Majid Ghayour-Mobarhan2؛ Sadegh Vahabi Amlashi3 | ||
1Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
2Biochemistry and Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
3Dermatology Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
چکیده | ||
According to the literature, schizophrenia is associated with the components of metabolic syndrome. This mental disorder has such manifestations as visceral obesity, impaired lipid metabolism, hyperglycemia, and hypertension. The prevalence rate of schizophrenia varies in different countries. There is a body of evidence about the higher incidence of cardiovascular events in the schizophrenic patients with metabolic syndrome. Therefore, the prevention or treatment of this condition in sthese patients is a matter of fundamental importance. Fish oils, commonly used by people, contain omega-3 fatty acid. Omega-3 has been demonstrated to be effective in the patients with metabolic syndrome. | ||
آمار تعداد مشاهده مقاله: 1,141 تعداد دریافت فایل اصل مقاله: 1,171 |